Literature DB >> 30849593

Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.

Miriama Simunkova1, Peter Lauro2, Klaudia Jomova2, Lenka Hudecova2, Martin Danko3, Saleh Alwasel4, Ibrahim M Alhazza4, Simona Rajcaniova5, Zuzana Kozovska5, Lucia Kucerova5, Jan Moncol6, Lubomir Svorc7, Marian Valko8.   

Abstract

Copper(II) complexes containing non-steroidal anti-inflammatory drugs (NSAIDs) have been the subject of many research papers and reviews. Here we report the synthesis, spectroscopic study and biological activity of novel mixed copper(II) complexes with NSAIDs: tolfenamic (tolf), mefenamic (mef) and flufenamic (fluf) acids and phenanthroline (phen): [Cu(tolf-O,O')2(phen)] (1), [Cu(mef-O,O')2(phen)] (2), [Cu(fluf-O,O')2(phen)] (3). Complexes were characterized by X-ray analysis and EPR spectroscopy. Complexes 1-3 are monomeric, six-coordinate and crystallize in a monoclinic space group. Interaction of Cu(II) complexes with DNA was studied by means of absorption titrations, viscosity measurements and gel electrophoresis. The relative ability of the complexes to cleave DNA even in the absence of hydrogen peroxide is in the order 3 > 2 > 1. Application of the reactive oxygen species (ROS) scavengers, L-histidine, DMSO and SOD confirmed that singlet oxygen, hydroxyl radicals (Fenton reaction) and superoxide radical were formed, respectively. Thus, in addition to mechanism of intercalation, redox-cycling mechanism which in turn lead to the formation of ROS contribute to DNA damage. Cu(II) complexes exhibit excellent SOD-mimetic activity in the order 3~1 > 2. The fluorescence spectroscopy revealed that albumin may act as a targeted drug delivery vehicle for Cu(II) complexes (K~106). The anticancer activities of complexes 1-3 were investigated using an MTS assay (reduction of the tetrazolium compound) against three cancer cell lines (HT-29 human colon adenocarcinoma, HeLa and T-47D breast cancer cells) and mesenchymal stromal cells (MSC). The most promising compound, from the viewpoint of its NSAID biological activity is 3, due to the presence of the three fluorine atoms participating in the formation of weak hydrogen-bonds at the DNA surface.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer activity; Cu complexes; Intercalation; NSAID, Phenanthroline; SOD activity

Mesh:

Substances:

Year:  2019        PMID: 30849593     DOI: 10.1016/j.jinorgbio.2019.02.010

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  5 in total

1.  Copper(II) Complexes with Mixed Heterocycle Ligands as Promising Antibacterial and Antitumor Species.

Authors:  Arpad Mihai Rostas; Mihaela Badea; Lavinia L Ruta; Ileana C Farcasanu; Catalin Maxim; Mariana Carmen Chifiriuc; Marcela Popa; Mirela Luca; Natasa Celan Korosin; Romana Cerc Korosec; Mihaela Bacalum; Mina Raileanu; Rodica Olar
Journal:  Molecules       Date:  2020-08-19       Impact factor: 4.411

2.  A selective CuII complex with 4-fluorophenoxyacetic acid hydrazide and phenanthroline displays DNA-cleaving and pro-apoptotic properties in cancer cells.

Authors:  Pedro Henrique Alves Machado; Drielly Aparecida Paixão; Ricardo Campos Lino; Tiago Rodrigues de Souza; Nayara Júnia de Souza Bontempo; Luana Munique Sousa; Fernanda Van Petten de Vasconcelos Azevedo; Priscila Capelari Orsolin; Paula Marynella Alves Pereira Lima; Isabella Castro Martins; Joyce Ferreira da Costa Guerra; Samuel Cota Teixeira; Thaise Gonçalves Araújo; Luiz Ricardo Goulart; Sandra Morelli; Wendell Guerra; Robson José de Oliveira Júnior
Journal:  Sci Rep       Date:  2021-12-27       Impact factor: 4.379

3.  Comparative Study of Antioxidant and Pro-Oxidant Properties of Homoleptic and Heteroleptic Copper Complexes with Amino Acids, Dipeptides and 1,10-Phenanthroline: The Quest for Antitumor Compounds.

Authors:  Nicolás Veiga; Natalia Alvarez; Eduardo E Castellano; Javier Ellena; Gianella Facchin; María H Torre
Journal:  Molecules       Date:  2021-10-28       Impact factor: 4.411

4.  Copper(ii) complexes with terpene derivatives of ethylenediamine: synthesis, and antibacterial, antifungal and antioxidant activity.

Authors:  Yana A Gur'eva; Olga A Zalevskaya; Oksana G Shevchenko; Pavel A Slepukhin; Vadim A Makarov; Aleksandr V Kuchin
Journal:  RSC Adv       Date:  2022-03-23       Impact factor: 3.361

Review 5.  Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy.

Authors:  Marzieh Anjomshoa; Bagher Amirheidari
Journal:  Coord Chem Rev       Date:  2022-02-05       Impact factor: 22.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.